Shares in Bellerophon Therapeutics (NSDQ:BLPH) fell slightly today after the company missed EPS expectations on Wall Street with its third quarter results.
The Warren, N.J.-based company posted a net loss of -$7.6 million for the 3 months ended Sept. 30, for bottom-line loss of -81% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Bellerophon Therapeutics misses EPS estimates in Q3 appeared first on MassDevice.
from MassDevice http://ift.tt/2hlplak
Cap comentari:
Publica un comentari a l'entrada